Literature DB >> 20565573

Evidence for separation of HCV subtype 1a into two distinct clades.

B E Pickett1, R Striker, E J Lefkowitz.   

Abstract

The nucleotide sequence diversity present among hepatitis C virus (HCV) isolates allows rapid adjustment to exterior forces including host immunity and drug therapy. This viral response reflects a combination of a high rate of replication together with an error-prone RNA-dependent RNA polymerase, providing for the selection and proliferation of the viruses with the highest fitness. We examined HCV subtype 1a whole-genome sequences to identify positions contributing to genotypic and phenotypic diversity. Phylogenetic tree reconstructions showed two distinct clades existing within the 1a subtype with each clade having a star-like tree topology and lacking definite correlation between time or place of isolation and phylogeny. Identification of significant phylogenetically informative sites at the nucleotide level revealed positions not only contributing to clade differentiation, but which are located at or proximal to codons associated with resistance to protease inhibitors (NS3 Q41) or polymerase inhibitors (NS5B S368). Synonymous/nonsynonymous substitution mutation analyses revealed that the majority of nucleotide mutations yielded synonymous amino acids, indicating the presence of purifying selection pressure across the polyprotein with pockets of positive selection also being detected. Despite evidence for divergence at several loci, certain 1a characteristics were preserved including the length of the alternative reading frame/F protein (ARF/F) gene, and a subtype 1a-specific phosphorylation site in NS5A (S349). Our analysis suggests that there may be strain-specific differences in the development of antiviral resistance to viruses infecting patients who are dependent on the genetic variation separating these two clades.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20565573      PMCID: PMC2964416          DOI: 10.1111/j.1365-2893.2010.01342.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  53 in total

1.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Authors:  Koichiro Tamura; Joel Dudley; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2007-05-07       Impact factor: 16.240

2.  Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

Authors:  Hari S Conjeevaram; Michael W Fried; Lennox J Jeffers; Norah A Terrault; Thelma E Wiley-Lucas; Nezam Afdhal; Robert S Brown; Steven H Belle; Jay H Hoofnagle; David E Kleiner; Charles D Howell
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

3.  Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.

Authors:  D Dhar; K Mapa; R Pudi; P Srinivasan; K Bodhinathan; S Das
Journal:  Arch Virol       Date:  2005-09-30       Impact factor: 2.574

4.  Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha.

Authors:  Yi Zhou; Ute Müh; Brian L Hanzelka; Doug J Bartels; Yunyi Wei; B Govinda Rao; Debra L Brennan; Ann M Tigges; Lora Swenson; Ann D Kwong; Chao Lin
Journal:  J Biol Chem       Date:  2007-06-06       Impact factor: 5.157

Review 5.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

6.  Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy.

Authors:  Maureen J Donlin; Nathan A Cannon; Ermei Yao; Jia Li; Abdus Wahed; Milton W Taylor; Steven H Belle; Adrian M Di Bisceglie; Rajeev Aurora; John E Tavis
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

7.  Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes.

Authors:  Julian Schulze zur Wiesch; Georg M Lauer; Cheryl L Day; Arthur Y Kim; Kei Ouchi; Jared E Duncan; Alysse G Wurcel; Joerg Timm; Andrea M Jones; Bianca Mothe; Todd M Allen; Barbara McGovern; Lia Lewis-Ximenez; John Sidney; Alessandro Sette; Raymond T Chung; Bruce D Walker
Journal:  J Immunol       Date:  2005-09-15       Impact factor: 5.422

8.  Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.

Authors:  Thomas von Hahn; Joo Chun Yoon; Harvey Alter; Charles M Rice; Barbara Rehermann; Peter Balfe; Jane A McKeating
Journal:  Gastroenterology       Date:  2006-12-03       Impact factor: 22.682

9.  Establishment of a pipeline to analyse non-synonymous SNPs in Bos taurus.

Authors:  Michael A Lee; Orla M Keane; Belinda C Glass; Tim R Manley; Neil G Cullen; Ken G Dodds; Alan F McCulloch; Chris A Morris; Mark Schreiber; Jonathan Warren; Amonida Zadissa; Theresa Wilson; John C McEwan
Journal:  BMC Genomics       Date:  2006-11-26       Impact factor: 3.969

10.  Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.

Authors:  John M Robida; Heather B Nelson; Zhe Liu; Hengli Tang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

View more
  30 in total

1.  Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing.

Authors:  Michael Lauck; Mónica V Alvarado-Mora; Ericka A Becker; Dipankar Bhattacharya; Rob Striker; Austin L Hughes; Flair J Carrilho; David H O'Connor; João R Rebello Pinho
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 2.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

3.  Naturally occurring genotype 2b/1a hepatitis C virus in the United States.

Authors:  Dipankar Bhattacharya; Molly A Accola; Israr H Ansari; Rob Striker; William M Rehrauer
Journal:  Virol J       Date:  2011-10-03       Impact factor: 4.099

4.  Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies.

Authors:  K L Berger; J Scherer; M Ranga; N Sha; J O Stern; A-M Quinson; G Kukolj
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

5.  Partial nonstructural 3 region analysis of hepatitis C virus genotype 3a.

Authors:  Anusorn Kiattanaphon; Yaovaluk Vipsoongnern; Duangkamol Kunthalert; Anchalee Sistayanarain
Journal:  Mol Biol Rep       Date:  2022-08-24       Impact factor: 2.742

6.  Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir.

Authors:  Kristi L Berger; Ibtissem Triki; Mireille Cartier; Martin Marquis; Marie-Josée Massariol; Wulf O Böcher; Yakov Datsenko; Gerhard Steinmann; Joseph Scherer; Jerry O Stern; George Kukolj
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

7.  Metadata-driven comparative analysis tool for sequences (meta-CATS): an automated process for identifying significant sequence variations that correlate with virus attributes.

Authors:  B E Pickett; M Liu; E L Sadat; R B Squires; J M Noronha; S He; W Jen; S Zaremba; Z Gu; L Zhou; C N Larsen; I Bosch; L Gehrke; M McGee; E B Klem; R H Scheuermann
Journal:  Virology       Date:  2013-09-14       Impact factor: 3.616

8.  Comprehensive cloning of patient-derived 9022-bp amplicons of hepatitis C virus.

Authors:  Yang Lu; Yanjuan Xu; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  J Virol Methods       Date:  2013-04-17       Impact factor: 2.014

9.  ViPR: an open bioinformatics database and analysis resource for virology research.

Authors:  Brett E Pickett; Eva L Sadat; Yun Zhang; Jyothi M Noronha; R Burke Squires; Victoria Hunt; Mengya Liu; Sanjeev Kumar; Sam Zaremba; Zhiping Gu; Liwei Zhou; Christopher N Larson; Jonathan Dietrich; Edward B Klem; Richard H Scheuermann
Journal:  Nucleic Acids Res       Date:  2011-10-17       Impact factor: 16.971

10.  Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.

Authors:  Rossana C Jaspe; Yoneira F Sulbarán; Maria Z Sulbarán; Carmen L Loureiro; Hector R Rangel; Flor H Pujol
Journal:  Virol J       Date:  2012-09-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.